Collection of Clinical Data and Specimens for Research on Head and Neck and Communication Disorders
NCT04618432 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 26
Last updated 2023-06-13
Summary
Study Description:
It may be in the interest of the NIDCD Clinical Research Program (CRP) to collect clinical data or specimens generated in the diagnosis and treatment of head and neck or communication disorders and to evaluate patients to determine candidacy for intramural clinical studies. This protocol will provide the administrative vehicle to enable the evaluation and provision of clinical care for patients with head and neck and communication disorders by the NIDCD CRP, Clinical Center, and consult services. No investigational therapies will be administered in this
study.
Objectives and Endpoints:
(Summation)To collect clinical data or specimens generated in the diagnosis and treatment of head and neck or communication disorders
(Summation)To evaluate patients to determine candidacy for intramural clinical studies
Study Population:
Patients at risk, suspected of having, have a history of, or currently have a diagnosed head and neck or communication disorder referred to NIDCD Clinical Investigators by the Intramural Consult Service or community providers
Description of Sites:
NIH Clinical Center
Study Duration:
10 years
Conditions
- Head and Neck Carcinoma
Sponsors & Collaborators
-
National Institute on Deafness and Other Communication Disorders (NIDCD)
lead NIH
Principal Investigators
-
Clint T Allen, M.D. · National Institute on Deafness and Other Communication Disorders (NIDCD)
Eligibility
- Min Age
- 2 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-11-03
- Primary Completion
- 2023-06-07
- Completion
- 2023-06-07
Countries
- United States
Study Locations
More Related Trials
-
A Retrospective Analysis of Neck Dissection Following Complete Response to Chemoradiation in HNSCC
NCT00483821 ·Status: COMPLETED
-
Evaluating the Use of an Informational Head and Neck Cancer Website.
NCT04268329 ·Status: TERMINATED ·Phase: NA
-
Head and Neck cancERs International cOviD-19 collabOraTion
NCT04632173 ·Status: UNKNOWN
-
Central Pain Syndrome in Survivors of Head and Neck Cancer
NCT04128267 ·Status: TERMINATED ·Phase: NA
-
A Pilot Study of Induction Chemotherapy Followed by Surgery for Locally Advanced Resectable Head and Neck Cancer
NCT01111942 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Individualized Follow-Up for Head and Neck Cancer
NCT05386225 ·Status: RECRUITING
-
Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation
NCT06662058 ·Status: RECRUITING ·Phase: NA
-
Customized Registry Tool for Tracking Adherence to Clinical Guidelines for Head and Neck Cancers
NCT03546322 ·Status: COMPLETED
-
Neuropathic Pain in Head and Neck Cancer
NCT01846286 ·Status: UNKNOWN
-
Analysis of Patterns of Recurrence in Head and Neck Cancer Using Clinicopathomic Markers
NCT04086849 ·Status: COMPLETED
-
Developing a Checklist of Lymphedema Symptoms in Patients With Head and Neck Cancer
NCT00840814 ·Status: COMPLETED
-
Role of Pharyngeal High Resolution Manometry and Impedance in Swallow Function of Head and Neck Cancer Patients
NCT03372148 ·Status: WITHDRAWN ·Phase: NA
-
Ficlatuzumab w/wo Cetuximab in Patients w/Cetuximab-Resistant, Recurrent or Metastatic Head/Neck Squamous Cell Carcinoma
NCT03422536 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Advanced Head and Neck Cancer
NCT00982696 ·Status: TERMINATED ·Phase: PHASE2
-
2 Phase Use Of Educational Materials In Head And Neck Cancer Center
NCT02204631 ·Status: COMPLETED ·Phase: NA
-
Capecitabine and Vorinostat in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer
NCT01267240 ·Status: TERMINATED ·Phase: PHASE2
-
Evaluation of Sleep Quality in Head and Neck Cancer Patients Throughout Treatment Course
NCT05108233 ·Status: WITHDRAWN
-
Study of Anxiety and Avoidance of Others in Patients Previously Treated for Head and Neck Cancer
NCT00483639 ·Status: COMPLETED
-
Cisplatin and Radiation Therapy in Treating Patients With Stage IV Cancer of the Head and Neck
NCT00002932 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Decreasing Radiation Therapy and Chemotherapy in People With Head and Neck Cancer
NCT05544136 ·Status: RECRUITING ·Phase: PHASE2
-
A Multicenter Study of Intensive Concomitant Chemoradiotherapy With Filgrastim (GCSF) for Patients With Locoregionally Advanced Head and Neck Cancer
NCT01693718 ·Status: COMPLETED ·Phase: PHASE2
-
Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer
NCT03010150 ·Status: RECRUITING
-
Nicotine Levels With Response Rates to Radiation Alone or With Chemo In Head & Neck Cancer
NCT01084733 ·Status: COMPLETED
-
Health and Economic Outcomes of Two Different Follow up Strategies in Effectively Cured Advanced Head and Neck Cancer
NCT02262221 ·Status: SUSPENDED ·Phase: NA
-
Afatinib and Nivolumab as Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
NCT03652233 ·Status: WITHDRAWN ·Phase: PHASE1